Picture of Davita logo

DVA Davita Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Annual cashflow statement for Davita, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-KPRESS
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,2127829571,2511,079
Depreciation
Deferred Taxes
Non-Cash Items119126201135269
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-1410.101195-29.8-263
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities1,9311,5652,0592,0221,887
Capital Expenditures-641-603-568-555-576
Purchase of Fixed Assets
Other Investing Cash Flow Items-143-26.9-204-216-79.1
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-785-630-772-771-655
Financing Cash Flow Items-239-270-298-427-393
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-1,083-1,121-1,170-817-1,375
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash53.2-216126415-122